ANDA 74399, held by Cosette Pharms Nc. Tolmetin Sodium.
As of Nov 16, 2026, ANDA 74399 (Tolmetin Sodium), held by Cosette Pharms Nc, was first approved by FDA on Mar 28, 1996, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 28, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tolmetin SodiumEQ 600MG BASE · tablet;oral | Tolmetin Sodium | Discontinued |
| Nov 21, 2024 | Supplement 5Labeling · Standard review | Approved | None posted |
| Apr 28, 2021 | Supplement 4Labeling · Standard review | Approved | None posted |
| May 9, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jul 29, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Mar 28, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters